Cytokinetics · 10 hours ago
Intern – Global Supply Chain & Data Science
Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology. They are seeking a highly motivated Intern to join their Global Supply Chain & Data Science group to enhance operational monitoring capabilities and deliver digital assets for Logistics stakeholders.
BiopharmaBiotechnologyHealth Care
Responsibilities
Engage with the Global Logistics function to enhance operational monitoring capabilities in the post-launch environment
Deliver digital assets which increase the speed of Logistics decision-making, shorten the time needed to identify logistics exceptions, and reduce manual effort in Logistics reporting
Serve Logistics stakeholders, with secondary responsibilities in Planning, Finance, Clinical Supply Chain, Procurement, and Change Management
Engage with the program management and portfolio team in order to properly register digital assets
Qualification
Required
Pursuing BS degree in Supply Chain, Industrial Engineering, Data Science or related area
Proficient in data modeling using SQL; understanding of Python, R, or other scripting languages
Demonstrated ability to work collaboratively across teams and contribute to continuous improvement initiatives
Strong analytical and problem-solving skills with the ability to support projects and meet defined deliverables
Clear written and verbal communication skills, with the ability to summarize data and present information effectively
Preferred
Experience with Excel and Tableau, including data organization, basic calculations, and development of dashboards and visualizations is a bonus
Company
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Funding
Current Stage
Public CompanyTotal Funding
$2.41BKey Investors
Royalty PharmaDeerfieldVulcan
2025-09-16Post Ipo Debt· $650M
2024-05-22Post Ipo Equity· $550M
2024-05-22Post Ipo Debt· $50M
Recent News
GlobeNewswire
2026-01-13
Company data provided by crunchbase